

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55177043 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55177043 |
| 3 | detection of other organism (GO:0098543) | 4.35564215 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34081568 |
| 5 | detection of bacterium (GO:0016045) | 4.19499433 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83839430 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 3.83839430 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83839430 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83839430 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83839430 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.83839430 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77739147 |
| 13 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71446667 |
| 14 | positive regulation of histone deacetylation (GO:0031065) | 3.69918837 |
| 15 | detection of external biotic stimulus (GO:0098581) | 3.69802512 |
| 16 | growth hormone receptor signaling pathway (GO:0060396) | 3.52022633 |
| 17 | regulation of mast cell degranulation (GO:0043304) | 3.46200102 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.45717881 |
| 19 | cellular extravasation (GO:0045123) | 3.44406611 |
| 20 | regulation of leukocyte degranulation (GO:0043300) | 3.42054370 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.37600354 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37600354 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.34013386 |
| 24 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.32862327 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32706506 |
| 26 | response to laminar fluid shear stress (GO:0034616) | 3.31712218 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30844363 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.30321838 |
| 29 | positive regulation of lamellipodium assembly (GO:0010592) | 3.27829676 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.27065517 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24480220 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.20906684 |
| 33 | morphogenesis of an endothelium (GO:0003159) | 3.16243900 |
| 34 | endothelial tube morphogenesis (GO:0061154) | 3.16243900 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15708376 |
| 36 | leukocyte aggregation (GO:0070486) | 3.14251593 |
| 37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12570368 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11356974 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10833426 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06371535 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04850796 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02822228 |
| 43 | cellular response to growth hormone stimulus (GO:0071378) | 3.02528373 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.02120249 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99730836 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96599487 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96221802 |
| 48 | apoptotic cell clearance (GO:0043277) | 2.94958893 |
| 49 | macrophage activation (GO:0042116) | 2.94861179 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94351834 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 2.93306033 |
| 52 | germinal center formation (GO:0002467) | 2.90552288 |
| 53 | positive regulation of lamellipodium organization (GO:1902745) | 2.90433752 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 2.88141754 |
| 55 | type I interferon signaling pathway (GO:0060337) | 2.87064811 |
| 56 | cellular response to type I interferon (GO:0071357) | 2.87064811 |
| 57 | response to type I interferon (GO:0034340) | 2.85413322 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85188821 |
| 59 | tolerance induction (GO:0002507) | 2.85119154 |
| 60 | regulation of tolerance induction (GO:0002643) | 2.84301185 |
| 61 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84271364 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 2.83306514 |
| 63 | regulation of regulated secretory pathway (GO:1903305) | 2.82386795 |
| 64 | cortical actin cytoskeleton organization (GO:0030866) | 2.80833568 |
| 65 | positive regulation of protein deacetylation (GO:0090312) | 2.76729095 |
| 66 | microglial cell activation (GO:0001774) | 2.76172045 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75419335 |
| 68 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75398051 |
| 69 | response to interleukin-15 (GO:0070672) | 2.74495796 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72194735 |
| 71 | negative thymic T cell selection (GO:0045060) | 2.70269850 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69517572 |
| 73 | actin nucleation (GO:0045010) | 2.69152569 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68620652 |
| 75 | negative regulation of granulocyte differentiation (GO:0030853) | 2.68547087 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67949391 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67178339 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.67135758 |
| 79 | germ cell migration (GO:0008354) | 2.66608953 |
| 80 | negative regulation of type 2 immune response (GO:0002829) | 2.65894997 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65482675 |
| 82 | macrophage activation involved in immune response (GO:0002281) | 2.65177879 |
| 83 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.64178286 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.64066911 |
| 85 | protein localization to endosome (GO:0036010) | 2.63770406 |
| 86 | respiratory burst (GO:0045730) | 2.63044695 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.62878900 |
| 88 | leukocyte cell-cell adhesion (GO:0007159) | 2.61434893 |
| 89 | NIK/NF-kappaB signaling (GO:0038061) | 2.60039283 |
| 90 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59122274 |
| 91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58499105 |
| 92 | pinocytosis (GO:0006907) | 2.58265558 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56620387 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 2.56620387 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.56548775 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.56141301 |
| 97 | T cell selection (GO:0045058) | 2.56075187 |
| 98 | response to fluid shear stress (GO:0034405) | 2.55618066 |
| 99 | thymic T cell selection (GO:0045061) | 2.55593699 |
| 100 | regulation of antigen processing and presentation (GO:0002577) | 2.55429692 |
| 101 | neutrophil activation involved in immune response (GO:0002283) | 2.55246907 |
| 102 | negative regulation of innate immune response (GO:0045824) | 2.53961252 |
| 103 | response to peptidoglycan (GO:0032494) | 2.53734828 |
| 104 | negative T cell selection (GO:0043383) | 2.53287210 |
| 105 | defense response to protozoan (GO:0042832) | 2.53121785 |
| 106 | negative regulation of fatty acid transport (GO:2000192) | 2.51877293 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 2.51510794 |
| 108 | regulation of B cell differentiation (GO:0045577) | 2.50501705 |
| 109 | positive regulation of leukocyte degranulation (GO:0043302) | 2.49956323 |
| 110 | barbed-end actin filament capping (GO:0051016) | 2.49874373 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.49102119 |
| 112 | stress fiber assembly (GO:0043149) | 2.47243682 |
| 113 | endodermal cell differentiation (GO:0035987) | 2.46842890 |
| 114 | T cell apoptotic process (GO:0070231) | 2.46729286 |
| 115 | response to host (GO:0075136) | 2.46647727 |
| 116 | response to host defenses (GO:0052200) | 2.46647727 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.46647727 |
| 118 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.46082904 |
| 119 | natural killer cell differentiation (GO:0001779) | 2.45990481 |
| 120 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45551093 |
| 121 | response to host immune response (GO:0052572) | 2.45551093 |
| 122 | regulation of macrophage cytokine production (GO:0010935) | 2.43776998 |
| 123 | substrate-dependent cell migration (GO:0006929) | 2.40399433 |
| 124 | regulation of protein heterodimerization activity (GO:0043497) | 2.40268764 |
| 125 | integrin-mediated signaling pathway (GO:0007229) | 2.39138865 |
| 126 | mannose metabolic process (GO:0006013) | 2.38998296 |
| 127 | establishment of endothelial barrier (GO:0061028) | 2.38391542 |
| 128 | basement membrane organization (GO:0071711) | 2.37462289 |
| 129 | hyaluronan catabolic process (GO:0030214) | 2.34589890 |
| 130 | response to fungus (GO:0009620) | 2.34515368 |
| 131 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32723830 |
| 132 | cortical cytoskeleton organization (GO:0030865) | 2.32621133 |
| 133 | angiogenesis involved in wound healing (GO:0060055) | 2.32552131 |
| 134 | B cell mediated immunity (GO:0019724) | 2.32211424 |
| 135 | neutrophil activation (GO:0042119) | 2.31933423 |
| 136 | positive regulation of interferon-alpha production (GO:0032727) | 2.31461999 |
| 137 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29517804 |
| 138 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.28514524 |
| 139 | sequestering of metal ion (GO:0051238) | 2.28193657 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28192281 |
| 141 | regulation of cholesterol storage (GO:0010885) | 2.28010560 |
| 142 | granulocyte activation (GO:0036230) | 2.27465857 |
| 143 | macrophage differentiation (GO:0030225) | 2.26879212 |
| 144 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.25888697 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.25665399 |
| 146 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.24336406 |
| 147 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.23343145 |
| 148 | mRNA stabilization (GO:0048255) | 2.22028220 |
| 149 | RNA stabilization (GO:0043489) | 2.22028220 |
| 150 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20754905 |
| 151 | regulation of interferon-alpha production (GO:0032647) | 2.20358586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.96112922 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.63678545 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.25040575 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97226480 |
| 5 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.96459303 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.71517546 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.62461033 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60329106 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54211038 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53964100 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53576453 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.49016308 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44537154 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40802714 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37034274 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36383709 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31832854 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.30782735 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29532637 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28405809 |
| 21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.26767349 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.25549039 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24471579 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.22205090 |
| 25 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.12855611 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.12833136 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12689556 |
| 28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.02766926 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93948816 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91839410 |
| 31 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.82096935 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.78316759 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76234225 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75739774 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75332470 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73267169 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71780294 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69386223 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65812114 |
| 40 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64327323 |
| 41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63265672 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62782188 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61293704 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.60326659 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59398634 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59253276 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56588491 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.54281960 |
| 49 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53985785 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50441162 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45959985 |
| 52 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44587988 |
| 53 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41585484 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41026910 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38108545 |
| 56 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37087098 |
| 57 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36186404 |
| 58 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35385095 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35240200 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34369404 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34020438 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31081962 |
| 63 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30994576 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28086613 |
| 65 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24850889 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24727414 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24680601 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22101520 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21917794 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19253834 |
| 71 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18072305 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17328316 |
| 73 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16552666 |
| 74 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16091379 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15691932 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13610031 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13226387 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12547836 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12122240 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11637067 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11535642 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11112043 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10484229 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09856267 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09698128 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09460675 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08717814 |
| 88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08332997 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08302074 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07575227 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06262963 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06257899 |
| 93 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05582743 |
| 94 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05181479 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04914731 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04488963 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03866436 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03063337 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02978703 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02852813 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02758093 |
| 102 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02587379 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02585266 |
| 104 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.00870220 |
| 105 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00846037 |
| 106 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00433013 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00309308 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 1.00261880 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99619885 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99514305 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98045823 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96957751 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96285340 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95450612 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94276845 |
| 116 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94262429 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92369371 |
| 118 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91709324 |
| 119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90930566 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90477656 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90125343 |
| 122 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89928767 |
| 123 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89842265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003303_peritoneal_inflammation | 2.89755234 |
| 2 | MP0009278_abnormal_bone_marrow | 2.81477117 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.80942118 |
| 4 | MP0003436_decreased_susceptibility_to | 2.59697205 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.40453383 |
| 6 | * MP0003300_gastrointestinal_ulcer | 2.35314051 |
| 7 | MP0005076_abnormal_cell_differentiation | 2.34345291 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.26922402 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.18478003 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.13987552 |
| 11 | MP0008260_abnormal_autophagy | 1.98785404 |
| 12 | MP0005058_abnormal_lysosome_morphology | 1.98549443 |
| 13 | MP0003279_aneurysm | 1.96494192 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 1.87133811 |
| 15 | MP0005000_abnormal_immune_tolerance | 1.85218001 |
| 16 | MP0004510_myositis | 1.85089707 |
| 17 | * MP0002419_abnormal_innate_immunity | 1.83009642 |
| 18 | * MP0002452_abnormal_antigen_presenting | 1.82745852 |
| 19 | * MP0001790_abnormal_immune_system | 1.80097800 |
| 20 | * MP0005387_immune_system_phenotype | 1.80097800 |
| 21 | * MP0001800_abnormal_humoral_immune | 1.77814300 |
| 22 | * MP0000685_abnormal_immune_system | 1.75779094 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.68361293 |
| 24 | MP0002405_respiratory_system_inflammati | 1.67461353 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.66882335 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 1.66155542 |
| 27 | * MP0005025_abnormal_response_to | 1.66044871 |
| 28 | MP0006054_spinal_hemorrhage | 1.65791832 |
| 29 | MP0005451_abnormal_body_composition | 1.65677055 |
| 30 | * MP0001819_abnormal_immune_cell | 1.65566841 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.62452629 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.60485810 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.60485810 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.60471633 |
| 35 | MP0003448_altered_tumor_morphology | 1.57881142 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.56152652 |
| 37 | * MP0002723_abnormal_immune_serum | 1.55173121 |
| 38 | MP0009785_altered_susceptibility_to | 1.51302530 |
| 39 | MP0006082_CNS_inflammation | 1.50962178 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.49337272 |
| 41 | MP0005023_abnormal_wound_healing | 1.49153308 |
| 42 | MP0005671_abnormal_response_to | 1.48978900 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.48256181 |
| 44 | MP0000858_altered_metastatic_potential | 1.47425492 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.47114341 |
| 46 | MP0004947_skin_inflammation | 1.46625554 |
| 47 | * MP0002398_abnormal_bone_marrow | 1.46462103 |
| 48 | MP0002933_joint_inflammation | 1.45527063 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.45459837 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.45066662 |
| 51 | MP0001958_emphysema | 1.44931884 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.41914065 |
| 53 | MP0003091_abnormal_cell_migration | 1.37559812 |
| 54 | MP0004272_abnormal_basement_membrane | 1.35525339 |
| 55 | MP0003724_increased_susceptibility_to | 1.34635736 |
| 56 | * MP0000716_abnormal_immune_system | 1.34364364 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.34360592 |
| 58 | MP0000343_altered_response_to | 1.33172395 |
| 59 | MP0003690_abnormal_glial_cell | 1.32803049 |
| 60 | MP0010307_abnormal_tumor_latency | 1.31192425 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.30311627 |
| 62 | MP0000604_amyloidosis | 1.29084731 |
| 63 | MP0000733_abnormal_muscle_development | 1.29039769 |
| 64 | * MP0010155_abnormal_intestine_physiology | 1.28507596 |
| 65 | MP0004858_abnormal_nervous_system | 1.26896927 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.26133041 |
| 67 | MP0004883_abnormal_blood_vessel | 1.25131491 |
| 68 | MP0002722_abnormal_immune_system | 1.24643942 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.23990315 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.22435499 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.22280128 |
| 72 | MP0001851_eye_inflammation | 1.21641027 |
| 73 | MP0009764_decreased_sensitivity_to | 1.18419264 |
| 74 | * MP0001845_abnormal_inflammatory_respons | 1.18330414 |
| 75 | * MP0002429_abnormal_blood_cell | 1.17978613 |
| 76 | MP0001853_heart_inflammation | 1.15881166 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 1.14478205 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.13531177 |
| 79 | MP0001849_ear_inflammation | 1.12140816 |
| 80 | MP0005164_abnormal_response_to | 1.10924890 |
| 81 | MP0003045_fibrosis | 1.08404995 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.05896221 |
| 83 | MP0002132_abnormal_respiratory_system | 1.04356486 |
| 84 | * MP0000703_abnormal_thymus_morphology | 1.04040961 |
| 85 | MP0003329_amyloid_beta_deposits | 1.02332198 |
| 86 | MP0005390_skeleton_phenotype | 1.01335601 |
| 87 | MP0005623_abnormal_meninges_morphology | 1.00046081 |
| 88 | MP0002006_tumorigenesis | 0.99997839 |
| 89 | MP0009840_abnormal_foam_cell | 0.99539166 |
| 90 | MP0001915_intracranial_hemorrhage | 0.99285483 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.96765040 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.94392474 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.91233397 |
| 94 | MP0000249_abnormal_blood_vessel | 0.90795711 |
| 95 | MP0003075_altered_response_to | 0.90588429 |
| 96 | MP0001873_stomach_inflammation | 0.90581971 |
| 97 | * MP0000490_abnormal_crypts_of | 0.89103096 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.88569314 |
| 99 | MP0005409_darkened_coat_color | 0.88482341 |
| 100 | MP0001542_abnormal_bone_strength | 0.87929725 |
| 101 | MP0005275_abnormal_skin_tensile | 0.87064674 |
| 102 | MP0008004_abnormal_stomach_pH | 0.86822240 |
| 103 | MP0010630_abnormal_cardiac_muscle | 0.85052788 |
| 104 | MP0004381_abnormal_hair_follicle | 0.84014047 |
| 105 | MP0003795_abnormal_bone_structure | 0.81217089 |
| 106 | * MP0003828_pulmonary_edema | 0.80101323 |
| 107 | MP0001614_abnormal_blood_vessel | 0.79711076 |
| 108 | MP0002128_abnormal_blood_circulation | 0.79503039 |
| 109 | MP0005310_abnormal_salivary_gland | 0.78891190 |
| 110 | * MP0003866_abnormal_defecation | 0.77512687 |
| 111 | * MP0008469_abnormal_protein_level | 0.72652465 |
| 112 | MP0000920_abnormal_myelination | 0.72184647 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.71878062 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.69457444 |
| 115 | * MP0009763_increased_sensitivity_to | 0.68541984 |
| 116 | MP0005166_decreased_susceptibility_to | 0.65577531 |
| 117 | * MP0002019_abnormal_tumor_incidence | 0.65318361 |
| 118 | * MP0001663_abnormal_digestive_system | 0.62989933 |
| 119 | MP0005165_increased_susceptibility_to | 0.62332812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.22138045 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.79773531 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.76097608 |
| 4 | Cellulitis (HP:0100658) | 3.16009001 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.15957752 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.12869989 |
| 7 | Hematochezia (HP:0002573) | 3.11775058 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.10810342 |
| 9 | Optic neuritis (HP:0100653) | 3.00090822 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.00090822 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.90400769 |
| 12 | Stomatitis (HP:0010280) | 2.83202664 |
| 13 | Dysostosis multiplex (HP:0000943) | 2.82557318 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 2.76594136 |
| 15 | Increased density of long bones (HP:0006392) | 2.73259133 |
| 16 | Shallow orbits (HP:0000586) | 2.70541309 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 2.68850249 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 2.65064814 |
| 19 | Amyloidosis (HP:0011034) | 2.64245571 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.59474125 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59457192 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.57412851 |
| 23 | Mucopolysacchariduria (HP:0008155) | 2.54625525 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54625525 |
| 25 | Premature rupture of membranes (HP:0001788) | 2.52665820 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.51934364 |
| 27 | Urticaria (HP:0001025) | 2.48301836 |
| 28 | Hyperacusis (HP:0010780) | 2.45809767 |
| 29 | Peritonitis (HP:0002586) | 2.42326112 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41802552 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41802552 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41742183 |
| 33 | Aortic aneurysm (HP:0004942) | 2.41208340 |
| 34 | Vasculitis (HP:0002633) | 2.39437026 |
| 35 | Epistaxis (HP:0000421) | 2.37929793 |
| 36 | Myositis (HP:0100614) | 2.37652250 |
| 37 | Chronic otitis media (HP:0000389) | 2.36986795 |
| 38 | Obstructive lung disease (HP:0006536) | 2.36554769 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36554769 |
| 40 | Loss of speech (HP:0002371) | 2.35503260 |
| 41 | Recurrent viral infections (HP:0004429) | 2.33594412 |
| 42 | Nasal polyposis (HP:0100582) | 2.31561096 |
| 43 | Purpura (HP:0000979) | 2.30894996 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28363671 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28363671 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28363671 |
| 47 | Mitral valve prolapse (HP:0001634) | 2.28265278 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26896291 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.26387658 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.24728260 |
| 51 | Aortic dissection (HP:0002647) | 2.23509567 |
| 52 | Ankle contracture (HP:0006466) | 2.22317951 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.22205141 |
| 54 | Cervical subluxation (HP:0003308) | 2.22110337 |
| 55 | Hemoptysis (HP:0002105) | 2.20527288 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.19601219 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.19432035 |
| 58 | Encephalitis (HP:0002383) | 2.15689152 |
| 59 | Petechiae (HP:0000967) | 2.15207856 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.14916538 |
| 61 | Dilatation of the ascending aorta (HP:0005111) | 2.11668022 |
| 62 | Thin bony cortex (HP:0002753) | 2.11209599 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07819746 |
| 64 | Aneurysm (HP:0002617) | 2.06474070 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.05120509 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05120509 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.03760017 |
| 68 | Polygenic inheritance (HP:0010982) | 2.03724207 |
| 69 | Ulnar bowing (HP:0003031) | 2.03644394 |
| 70 | Gingival bleeding (HP:0000225) | 2.03097537 |
| 71 | Colitis (HP:0002583) | 2.02358215 |
| 72 | Bicuspid aortic valve (HP:0001647) | 2.01869391 |
| 73 | Genu recurvatum (HP:0002816) | 2.01828890 |
| 74 | Gingivitis (HP:0000230) | 2.01540399 |
| 75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.01313522 |
| 76 | Recurrent skin infections (HP:0001581) | 1.99854240 |
| 77 | Chest pain (HP:0100749) | 1.98448259 |
| 78 | Hepatosplenomegaly (HP:0001433) | 1.97885732 |
| 79 | Spondylolisthesis (HP:0003302) | 1.96615139 |
| 80 | Episodic fever (HP:0001954) | 1.96159951 |
| 81 | IgM deficiency (HP:0002850) | 1.95532494 |
| 82 | Broad metatarsal (HP:0001783) | 1.95202547 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 1.94590610 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.91687822 |
| 85 | Pulmonary embolism (HP:0002204) | 1.91463739 |
| 86 | Emphysema (HP:0002097) | 1.91302129 |
| 87 | Increased connective tissue (HP:0009025) | 1.90093817 |
| 88 | Obstructive sleep apnea (HP:0002870) | 1.89758608 |
| 89 | Thrombocytosis (HP:0001894) | 1.89483129 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 1.89268771 |
| 91 | Myocardial infarction (HP:0001658) | 1.89256401 |
| 92 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88937780 |
| 93 | Meningitis (HP:0001287) | 1.88803302 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 1.88731795 |
| 95 | Keratoconjunctivitis (HP:0001096) | 1.88216463 |
| 96 | Polycythemia (HP:0001901) | 1.86488956 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.86380402 |
| 98 | Sepsis (HP:0100806) | 1.86227820 |
| 99 | Short 4th metacarpal (HP:0010044) | 1.85254792 |
| 100 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.85254792 |
| 101 | Abnormal platelet volume (HP:0011876) | 1.84790443 |
| 102 | Papilloma (HP:0012740) | 1.84474734 |
| 103 | Verrucae (HP:0200043) | 1.84474734 |
| 104 | Restrictive lung disease (HP:0002091) | 1.84275599 |
| 105 | T lymphocytopenia (HP:0005403) | 1.84256405 |
| 106 | Broad face (HP:0000283) | 1.83687073 |
| 107 | Agammaglobulinemia (HP:0004432) | 1.81927490 |
| 108 | Increased IgE level (HP:0003212) | 1.81585023 |
| 109 | Upper motor neuron abnormality (HP:0002127) | 1.80808072 |
| 110 | Arterial thrombosis (HP:0004420) | 1.80801372 |
| 111 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80249968 |
| 112 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79249235 |
| 113 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79249235 |
| 114 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79249235 |
| 115 | Bladder diverticulum (HP:0000015) | 1.79167457 |
| 116 | Neurofibrillary tangles (HP:0002185) | 1.78757084 |
| 117 | Leukocytosis (HP:0001974) | 1.78502123 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.77383185 |
| 119 | Recurrent bronchitis (HP:0002837) | 1.76348742 |
| 120 | Skin ulcer (HP:0200042) | 1.75909837 |
| 121 | Enlarged penis (HP:0000040) | 1.75392988 |
| 122 | Subacute progressive viral hepatitis (HP:0006572) | 1.75188650 |
| 123 | Asymmetric septal hypertrophy (HP:0001670) | 1.74767211 |
| 124 | Abnormality of the fingertips (HP:0001211) | 1.74042955 |
| 125 | Hypochromic anemia (HP:0001931) | 1.73795726 |
| 126 | Vertebral compression fractures (HP:0002953) | 1.73543544 |
| 127 | Striae distensae (HP:0001065) | 1.73161520 |
| 128 | Orchitis (HP:0100796) | 1.73098412 |
| 129 | Axonal loss (HP:0003447) | 1.72647828 |
| 130 | Asymmetry of the thorax (HP:0001555) | 1.72471649 |
| 131 | Fatigue (HP:0012378) | 1.71161335 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.70950695 |
| 133 | Abnormal platelet function (HP:0011869) | 1.70950695 |
| 134 | Rectal prolapse (HP:0002035) | 1.70349576 |
| 135 | Pustule (HP:0200039) | 1.69956487 |
| 136 | Distal upper limb amyotrophy (HP:0007149) | 1.69673931 |
| 137 | Upper limb amyotrophy (HP:0009129) | 1.69673931 |
| 138 | High pitched voice (HP:0001620) | 1.68089372 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.67377839 |
| 140 | Disinhibition (HP:0000734) | 1.67194142 |
| 141 | Hand muscle atrophy (HP:0009130) | 1.65319422 |
| 142 | Osteomyelitis (HP:0002754) | 1.64910662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.74798043 |
| 2 | PKN2 | 3.59752370 |
| 3 | MAP4K1 | 3.31820381 |
| 4 | ERN1 | 3.10704644 |
| 5 | PRPF4B | 3.10569433 |
| 6 | EEF2K | 2.58319506 |
| 7 | MAP3K10 | 2.38206474 |
| 8 | EPHB1 | 2.16158323 |
| 9 | TTN | 2.15256984 |
| 10 | LRRK2 | 2.08065000 |
| 11 | STK10 | 2.06929120 |
| 12 | PTK6 | 2.06200677 |
| 13 | TGFBR2 | 1.96824678 |
| 14 | KDR | 1.80776620 |
| 15 | MAP3K13 | 1.80068754 |
| 16 | BLK | 1.77497579 |
| 17 | SMG1 | 1.72655949 |
| 18 | RIPK1 | 1.62727725 |
| 19 | PAK4 | 1.56120950 |
| 20 | SCYL2 | 1.54959493 |
| 21 | TNK2 | 1.54682193 |
| 22 | TYK2 | 1.54679643 |
| 23 | TBK1 | 1.54394776 |
| 24 | CDK12 | 1.54045286 |
| 25 | MAP3K14 | 1.48656842 |
| 26 | JAK3 | 1.47531151 |
| 27 | CSK | 1.45423227 |
| 28 | ZAP70 | 1.43400075 |
| 29 | MAP2K3 | 1.38934070 |
| 30 | BTK | 1.38864014 |
| 31 | BMX | 1.34075249 |
| 32 | TAOK2 | 1.31326064 |
| 33 | DMPK | 1.28519111 |
| 34 | KIT | 1.25965610 |
| 35 | CSF1R | 1.25305515 |
| 36 | TESK2 | 1.25013690 |
| 37 | GRK6 | 1.22587984 |
| 38 | KSR2 | 1.19912125 |
| 39 | PDGFRA | 1.18112836 |
| 40 | MARK2 | 1.16636132 |
| 41 | IRAK3 | 1.16254275 |
| 42 | RPS6KA4 | 1.14207897 |
| 43 | TIE1 | 1.13018735 |
| 44 | HCK | 1.12951010 |
| 45 | IRAK4 | 1.09786606 |
| 46 | CDC42BPA | 1.09438920 |
| 47 | ALK | 1.05996420 |
| 48 | JAK1 | 1.05379060 |
| 49 | SIK3 | 1.03547824 |
| 50 | MOS | 1.02227303 |
| 51 | FGFR4 | 1.01150836 |
| 52 | ITK | 1.00614301 |
| 53 | CAMK1D | 0.99960439 |
| 54 | SIK1 | 0.99213150 |
| 55 | FGFR3 | 0.95709241 |
| 56 | FES | 0.95287298 |
| 57 | CDK6 | 0.92941556 |
| 58 | TAOK3 | 0.91144953 |
| 59 | FLT3 | 0.90604054 |
| 60 | ILK | 0.90541488 |
| 61 | CLK1 | 0.89741451 |
| 62 | PTK2 | 0.86369668 |
| 63 | PDPK1 | 0.85719808 |
| 64 | TESK1 | 0.85616062 |
| 65 | JAK2 | 0.84427063 |
| 66 | SIK2 | 0.82560562 |
| 67 | PIM1 | 0.81143213 |
| 68 | MAP3K6 | 0.81015445 |
| 69 | NEK9 | 0.80643069 |
| 70 | MAP3K8 | 0.80530827 |
| 71 | EPHA3 | 0.79221232 |
| 72 | PIM2 | 0.78484308 |
| 73 | CAMK1G | 0.78169357 |
| 74 | TGFBR1 | 0.77016422 |
| 75 | NEK2 | 0.75651093 |
| 76 | LCK | 0.74759792 |
| 77 | NME2 | 0.74472001 |
| 78 | PRKCH | 0.74031523 |
| 79 | MAPK12 | 0.73952777 |
| 80 | HIPK2 | 0.73200907 |
| 81 | TRPM7 | 0.72637262 |
| 82 | PDK1 | 0.72544178 |
| 83 | MAPK7 | 0.72263218 |
| 84 | DYRK1B | 0.72143998 |
| 85 | MAP3K11 | 0.71588254 |
| 86 | RET | 0.70061709 |
| 87 | ARAF | 0.69912386 |
| 88 | PAK2 | 0.69349812 |
| 89 | MAP2K2 | 0.69208612 |
| 90 | TAOK1 | 0.68332863 |
| 91 | PDGFRB | 0.67653053 |
| 92 | MARK3 | 0.67413578 |
| 93 | SYK | 0.66927668 |
| 94 | FGR | 0.66626328 |
| 95 | CHUK | 0.62668387 |
| 96 | TEC | 0.61664883 |
| 97 | MATK | 0.59574843 |
| 98 | MAP3K7 | 0.59554622 |
| 99 | MTOR | 0.59538863 |
| 100 | TXK | 0.58421024 |
| 101 | IKBKB | 0.57327118 |
| 102 | FYN | 0.57274057 |
| 103 | YES1 | 0.56701900 |
| 104 | PRKD2 | 0.56341392 |
| 105 | IRAK2 | 0.56015578 |
| 106 | PRKG2 | 0.55716263 |
| 107 | ICK | 0.54742685 |
| 108 | IKBKE | 0.54295751 |
| 109 | MAP3K1 | 0.53551773 |
| 110 | RIPK4 | 0.53124490 |
| 111 | MAPKAPK2 | 0.52969063 |
| 112 | CDK4 | 0.51704777 |
| 113 | PRKD1 | 0.51318662 |
| 114 | MAP3K3 | 0.50089922 |
| 115 | RPS6KA6 | 0.49676858 |
| 116 | EGFR | 0.48504564 |
| 117 | STK38 | 0.48485028 |
| 118 | LYN | 0.47082764 |
| 119 | CAMKK1 | 0.46846064 |
| 120 | RPS6KL1 | 0.45880750 |
| 121 | RPS6KC1 | 0.45880750 |
| 122 | STK4 | 0.45098612 |
| 123 | RPS6KA2 | 0.44741700 |
| 124 | EPHB2 | 0.44578443 |
| 125 | CDK9 | 0.43077912 |
| 126 | GRK7 | 0.42452565 |
| 127 | DDR2 | 0.41833254 |
| 128 | SGK3 | 0.41708527 |
| 129 | PTK2B | 0.39121038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44051263 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13365625 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09371245 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98881006 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.96676659 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.93255987 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80444688 |
| 8 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.80413033 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78216740 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.77806224 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74792002 |
| 12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.67958367 |
| 13 | Shigellosis_Homo sapiens_hsa05131 | 1.65391447 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63910825 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63029524 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61853631 |
| 17 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.58802646 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56549170 |
| 19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50214378 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49106778 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.46196544 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44876876 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44642788 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.42334062 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41974543 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40897171 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.39039492 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37842380 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.36883781 |
| 30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.35874811 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34168742 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33071050 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31505672 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.30599733 |
| 35 | * Platelet activation_Homo sapiens_hsa04611 | 1.29923515 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.29659163 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.28513620 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28343700 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.27813471 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26562506 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26519382 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26026724 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25516731 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 1.24987295 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.24790208 |
| 46 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20930508 |
| 47 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20125282 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20102868 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19821678 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18376077 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 1.17543010 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17531669 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15487316 |
| 54 | * Pertussis_Homo sapiens_hsa05133 | 1.14454218 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.12119931 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.12114582 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10410292 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 1.09243771 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07115459 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07064277 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06756574 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05434289 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03833358 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99728046 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99305428 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.99213584 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98761043 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97388437 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94293824 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93027400 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.92622254 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91090169 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.89629444 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89343131 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.89311911 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88540523 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88083677 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.87576776 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86927709 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86493454 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82027662 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.80150410 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79144041 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78424641 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77375722 |
| 86 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.76667841 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75633242 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.74215279 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72045500 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.71678062 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70200248 |
| 92 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66999685 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66497417 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65479751 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64241650 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64107073 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63388819 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62847090 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62649635 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61738282 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60481717 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60479051 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59170013 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59092022 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58448666 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57889782 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.57140827 |
| 108 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56514105 |
| 109 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56291704 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55750934 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55408821 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54885143 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51512632 |
| 114 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49705124 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47230875 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.46248747 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45260998 |

